Cyclophosphamide and Abdominal wall abscess - a phase IV clinical study of FDA data

Summary:

Abdominal wall abscess is reported as a side effect among people who take Cyclophosphamide (cyclophosphamide), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Oncovin, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Abdominal wall abscess when taking Cyclophosphamide. It is created by eHealthMe based on reports of 185,094 people who have side effects when taking Cyclophosphamide from the FDA, and is updated regularly.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.

What is Abdominal wall abscess?

Abdominal wall abscess (abdominal wall infection) is found to be associated with 104 drugs and 453 conditions by eHealthMe. Check the latest studies of Abdominal wall abscess.

On Jul, 12, 2026

185,094 people reported to have side effects when taking Cyclophosphamide.
Among them, 26 people (0.01%) have Abdominal wall abscess.

Could Cyclophosphamide cause Abdominal wall abscess?

Among these 26 people:

How long have people been on Cyclophosphamide when they have Abdominal wall abscess? *

What is the gender of people who have Abdominal wall abscess when taking Cyclophosphamide? *

female: 20.83 %
male: 79.17 %

What is the age of people who have Abdominal wall abscess when taking Cyclophosphamide? *

What are other drugs people take besides Cyclophosphamide? *

What are other side effects people have besides Abdominal wall abscess? *

Ill-Defined Disorder: 14 people, 53.85%
Hepatotoxicity (chemical-driven liver damage): 12 people, 46.15%
Ascites (accumulation of fluid in the abdominal cavity): 3 people, 11.54%
Cardiac Failure: 3 people, 11.54%
Cardiac Failure Acute: 3 people, 11.54%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 3 people, 11.54%
Chronic Renal Failure (kidney failure): 3 people, 11.54%
Cor Pulmonale (enlargement of the right ventricle of the heart): 3 people, 11.54%
Disturbance In Attention: 3 people, 11.54%
Electrolyte Imbalance: 3 people, 11.54%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 21 people, 80.77%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 11.54%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 7.69%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 7.69%
Hepatitis C: 1 person, 3.85%
Glomerulonephritis Chronic (long lasting group of conditions that affect parts of the kidneys called glomeruli): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Cyclophosphamide and have Abdominal wall abscess?

- Check whether Abdominal wall abscess is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cyclophosphamide:

Cyclophosphamide (185,240 reports)

Browse all side effects of Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal wall abscess:

Abdominal wall abscess (104 drugs)

Browse all the conditions that are associated with Abdominal wall abscess:

Abdominal wall abscess (453 conditions)

Related publications that referenced our studies

Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on cyclophosphamide (the active ingredients of Cyclophosphamide) and Cyclophosphamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.